http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003503407-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-811
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D279-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F13-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D259-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D259-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-02
filingDate 2000-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2003-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2003503407-A
titleOfInvention Novel quaternary ammonium derivative, its preparation method and its pharmaceutical use
abstract (57) Abstract: The present invention provides a compound of the formula (Ia): wherein M represents a molecule for use in treating or diagnosing a condition affecting cartilage; R 1 , R 2 and R 3 represent Represents an alkyl group or R 1 , R 2 and R 3 together with the nitrogen atom they carry form a heterocyclic ring; X is one or several -CH 2 -groups, optionally, a sulfur atom, an oxygen atom, -NR -, - CO -, - CO-NH -, - CO 2 -, - SO- or -SO 2 - is replaced by a group (C 1 -C 6) alkyl Represents a chain; n is 0 or 1; Hal represents a halogen atom]; or formula (Ib): wherein R 4 represents an alkyl group; Hal represents a halogen atom. The compound of Formula (F1) represents a molecule for use in the treatment or diagnosis of a condition affecting cartilage, provided that the nitrogen atom is optionally included in a saturated or unsaturated nitrogen-containing heterocyclic system or It can be included in a double bond.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015509966-A
priorityDate 1999-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395488
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17934447
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226404047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232301431
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID460612
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676228

Total number of triples: 46.